Toripalimab Combined With Radiotherapy and Chemotherapy in the Treatment of SNMM After Endoscopic Surgery

Key facts

Sponsor

Eye & ENT Hospital of Fudan University

Principal Investigator

Hongmeng Yu, MD,PHD

Eye&ENT Hospital,Fudan University

Intervention

endoscopic surgery(procedure)

Enrollment

45 enrolled

Eligibility

18 years · All sexes

Timeline

2021 – 2026

Study locations (1)

• Eye& ENT Hospital, Fudan University, Shanghai, Shanghai Municipality, China

Collaborators

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Malignant melanoma of the mucosa

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE2NCT06797297
  A Study to Evaluate the Efficacy and Safety of IBI363 Monotherapy Compared to Pembrolizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal or Acral Melanoma Who Had Not Previously Received Systemic Therapy
  Innovent Biologics (Suzhou) Co. Ltd.
• ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT05661955
  A Study to Investigate the Antitumor Activity, Safety, Tolerability, and Pharmacokinetics of BGB-A445 in Combination With Tislelizumab in Participants With Select Advanced Solid Tumors.
  BeiGene
• ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT05089370
  Oral Decitabine/Cedazuridine (DEC-C) in Combination With Nivolumab for Patients With Mucosal Melanoma
  University of Colorado, Denver

See all trials for Malignant melanoma of the mucosa →